Join to View Full Profile
Fred Hutchinson Cancer Research Center1100 Fairview Avenue NorthSeattle, WA 98109
Phone+1 206-667-6932
Dr. McDonald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oxford, Nuffield Dept. of Clinical MedicineSabbatical year of research, Gastroenterology, 1983 - 1984
University of WashingtonFellowship, Gastroenterology, 1972 - 1975- University of WashingtonResidency, Internal Medicine, 1967 - 1969
Washington University in St. Louis School of MedicineClass of 1967
Certifications & Licensure
WA State Medical License 1968 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Alpha Omega Alpha AOA, 1967
Publications & Presentations
PubMed
- Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease.George B McDonald, Ole J B Landsverk, Dermot P B McGovern, Anders Aasebø, Vemund Paulsen
Heliyon. 2024-01-15 - 151 citationsSurvival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.George B. McDonald, Brenda M. Sandmaier, Marco Mielcarek, Mohamed L. Sorror, Steven A. Pergam
Annals of Internal Medicine. 2020-02-18 - 4 citationsCytomegalovirus hepatitis after bone marrow transplantation: An autopsy study with clinical, histologic and laboratory correlates.George B. McDonald, Juan I Sarmiento, Georgia Rees-Lui, David Myerson
Journal of Viral Hepatitis. 2019-11-01
Journal Articles
- Liver Complications Following Treatment of Hematologic Malignancy with Anti‐cd22‐Calicheamicin (Inotuzumab Ozogamicin)James W Freston, Laurie D DeLeve, George B McDonald, Hepatology
Press Mentions
Lumen Bioscience's LMN-201 Achieves 100% Initial C. Difficile Clinical Cure in Preliminary Cohort of RePreve TrialApril 3rd, 2025
How a Phone Call Helped Shape the Field of Bone Marrow TransplantJanuary 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
